BioCatalyst

CELC — Celcuity Inc. catalysts

1 verified catalyst event(s) for Celcuity Inc. (ticker CELC). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-06-30 — Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treat · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-06-30
in 8d
ESTIMATED
 READOUT
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for
Phase 3 · Breast Cancer
 CELC Celcuity Inc. Gedatolisib, Palbociclib, Fulvestrant, A ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.